News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Rita A. Sakr: Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype
Rita A. Sakr/LinkedIn
Apr 27, 2025, 11:50

Rita A. Sakr: Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype

Rita A. Sakr, Breast Surgery Director at Emirates Hospitals Group, shared a post on LinkedIn:

“Very happy to be part of an international work about the impact of Oncoplastic surgery on BCS positive margins in lobular vs ductal invasive breast cancer.”

Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery

Authors: Kayla M. Switalla et al.

Rita A. Sakr: Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype

cancer Kayla M. Switalla OncoDaily Oncology oncoplastic surgery Rita A. Sakr
Special Coverage
Voices
Sep 2, 2025, 15:45
Preparing NSCLC for the Future of Diagnostic Biomarker Testing - IASCL
Societies
Sep 2, 2025, 15:45
Gold September 2025: Add Your Voice to the SIOPE Virtual Awareness Wall for Paediatric Oncology
Science
Sep 2, 2025, 15:43
Vineet Datta: A Decade Ago I Read Chetan Bettegowda’s Landmark 2014 Study, Now I’m Honored to Collaborate with Him
Voices
Sep 2, 2025, 15:32
Douglas Flora: Beyond the MCAT - Choosing Doctors for an AI Age
Voices
Sep 2, 2025, 15:27
The Dorcas Cancer Foundation Presents PedROC September Series
Voices
Sep 2, 2025, 15:23
Sophie Bussmann-Kemdjo: Turning Ambition Into Action, and Action Into Lasting Systems Change
Voices
Sep 2, 2025, 15:22
Every Child Deserves a Future Free from the Shadows of Cancer - Medicaid Cancer Foundation
Blog Posts
Sep 2, 2025, 15:21
Highlights from Danish Cancer Research Days 2025 - Danish Cancer Institute
Immune Oncology
Sep 2, 2025, 15:16
Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to Watch at ESMO 2025
Voices
Sep 2, 2025, 15:11
Hassan R. Hashmi: A Reminder to Honor the Hard Work and Dedication Across All Fields
Science
Sep 2, 2025, 15:08
Ropeginterferon Redefines Second-Line Therapy in High-Risk Essential Thrombocythemia - Hematology Frontier
Career Updates
Sep 2, 2025, 15:05
Devika Das as New Division Director at the University of Mississippi Medical Center